CD28 Costimulation Mediates Down-Regulation of p27<i>kip1</i> and Cell Cycle Progression by Activation of the PI3K/PKB Signaling Pathway in Primary Human T Cells
Leonard J. Appleman(University of Pittsburgh), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Lee M. Nadler(Dana-Farber Cancer Institute), André A. F. L. van Puijenbroek(Harvard University), Kirstin M. Shu(Brigham and Women's Hospital)
Cited by 200
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k